Post by Victor Zeijen

Just published in the Journal of Hypertension, our manuscript entitled: 'Long-term safety and efficacy of renal sympathetic denervation in comparison to a population-based cohort: a propensity-matching approach' What's new? ✅ First to apply a propensity-matched study design in the field of interventional treatment options for hypertension ✅ Longest follow-up duration including a control group in the literature Key findings at 5 years: 🔷 Sustained blood pressure reductions following renal denervation, though not greater than those observed in the control group 🔷 Comparable risks for future cardiovascular events in patients undergoing renal denervation as compared to matched controls 🔷 No signs of an adverse effect of renal denervation on kidney function, supporting the long-term safety of the therapy Future perspectives: 📌 Underscoring the importance of long-term outcomes of randomized controlled trials 📌 Highlighting the unmet need for dedicated longitudinal registry studies in patients with difficult-to-treat hypertension https://lnkd.in/e4-xRiQB Martijn Tilly Kari Saville Bruno Stricker Isabella Kardys Kamran Ikram Maryam Kavousi Joost Daemen